Philadelphia Business Journal’s Post

Read NEMICS latest report: 𝗜𝗺𝗽𝗿𝗼𝘃𝗶𝗻𝗴 𝗟𝗚𝗕𝗧𝗜𝗤𝗔+ 𝗖𝗮𝗻𝗰𝗲𝗿 𝗖𝗮𝗿𝗲 People who identify as lesbian, gay, bisexual, trans, intersex, queer/questioning, asexual, and other sexual and gender minorities (LGBTIQA+) may be at greater risk of developing cancer and are likely to have poorer outcomes. The Victorian Cancer Plan 2020–2024 highlights the LGBTIQA+ community as a priority population group, but there is limited understanding of the barriers and enablers to high-quality cancer care for this community. NEMICS examined: • LGBTIQA+ acknowledgment, inclusion, and targeted action in Australian cancer policy • published evidence of experience, barriers, facilitators, and recommendations on care for LGBTIQA+ people with cancer • whether sexual orientation and gender identity identifiers are present in Victorian datasets. This work has identified a range of improvement priorities including: • the need for clinical leadership and consumer advocacy • introduction of data items and improved definitions within cancer datasets; and • better monitoring of distress • improving the treatment environment NEMICS will work with our partner health services to create an improvement plan. For further information, see the summary report and recommendations: https://bit.ly/3KkDdvT Northern Health Austin Health Eastern Health Mercy Health Australia #cancer #lgbtqiaplus #LGBTIQA+  

The report showed progress against cancer is hampered by wide static cancer disparities. Compared to White people, mortality rates are two‐fold higher for prostate, stomach, and uterine corpus cancers in Black people and for liver, stomach, and kidney cancers in Native American people. This year’s report also includes a special section: Cancer in People Who Identify as Lesbian, Gay, Bisexual, Transgender, Queer or Gender-nonconforming (LGBTQ+).

This post is a few years old, but still relevant this month and every other for the LGBTQIA+ community in preventing & treating cancer: 1. Find a doctor you can trust: Did you know about the Healthcare Equality Index? https://lnkd.in/gVmWAMYn 2. Stay on top of routine exams & screenings 3. Know that hormone therapy can affect cancer risk 4. Be mindful of alcohol, drug & tobacco use in relation to cancer 5. Get the HPV vaccine 6. Make exercise a priority 7. Find specific providers & programs that cater to your unique needs Stay healthy and happy #PrideMonth! 🌈 https://lnkd.in/g3adS8KY

As #WorldCancerDay approaches, we emphasize the imperative to end inequity in cancer prevention and care. In Women, power and cancer: A Lancet Commission report, published last year, our president Shirin Heidari and co-authors, highlighted the necessity of a transformative, intersectional feminist approach to tackle the under-recognised cancer burden in women. Read: https://lnkd.in/dU9mk6_R Shirin Heidari, Ophira Ginsburg, Erica Liebermann, PhD, ANP, WHNP, Jennifer Moodley, Jenna Bhimani, Sonia Menon MSc, MPH, MA, PhD, Carolyn Taylor, VERNA VANDERPUYE, Nirmala Bhoo Pathy MD PhD, Ibtihal Fadhil, Nazik Hammad, Deborah Mukherji, Rachel Nugent, Michelle Ann Eala, MD. The Lancet, ecancer, Geneva Graduate Institute, National Cancer Institute (NCI), ESMO - European Society for Medical Oncology, European Cancer Organisation, Union for International Cancer Control (UICC), European Institute for Gender Equality, GENDRO.ORG. #FigthCancer, #JoinTheCause, #CloseTheCareGap, #Gender, #Health, #HealthResearch, #HealthEquity, #GenderEquality, #WomensHealth, #CancerResearch.

"This Commission was created to investigate the nexus of women, power, and cancer. By applying an intersectional feminist approach, researchers investigate, expose, and challenge the prevailing asymmetries of power in relation to cancer in three key domains: decision-making, knowledge, and economics." #womenhealth #cancer #gender #innovation #creativity #futurism #startups #publichealth The Lancet Johns Hopkins Bloomberg School of Public Health

🌍Mark your calendars for our next webinar: "Advancing Global Health Equity: Investing in Integrated HIV, HPV, and Cervical Cancer Initiatives" on: 🕒 Date: May 30, 2024 📅 Day: Thursday ⏰ Time: 09:30 to 11:00 A.M EDT Hosted by amfAR, The Foundation for AIDS Research, Funders Concerned About AIDS (FCAA), & Funders For Reproductive Equity (FRE), this event delves into the crucial role philanthropy plays in driving integrated solutions for these pressing #health challenges. Did you know that HIV and cervical #cancer intersect in profound ways, particularly affecting #women in low- and middle-income countries? Despite commendable efforts from leading organizations such as the #GlobalFund, #PEPFAR, and Unitaid, critical gaps persist in delivering HPV vaccination, cervical cancer screening, and treatment programs to communities most in need. This webinar will feature a diverse panel of experts from the Biden Cancer Moonshot, Unitaid, the Elizabeth Glaser Pediatric AIDS Foundation, AVAC, and more. Together, we'll examine the implications of service integration on programs, #policy, and #research, and discuss how to center #racial and #gender justice in this critical work. 🔍 Key questions guiding our conversation include: 🔹 What are the implications of service integration on programs, policy, and research? 🔹 How do we center racial and gender justice in this work? 🔹 What are future directions philanthropy can take to address this critical need? Don't miss this opportunity to gain multi-sector perspectives and contribute to meaningful dialogue. Register now to secure your spot: https://shorturl.at/dfgZ2 *Please note: Registration is limited to representatives of funding and philanthropy-serving organizations. #GlobalHealthEquity #HIV #HPV #CervicalCancer #Philanthropy

Our 24th volume is OUT, specially focused on #cancer! We have an Editorial: "#Research in cancer needs pivotal changes". Research studies on cancer from #India, #Bhutan; preventing cancer in #Asia & much more... Read the volume 👉 bit.ly/3JYNX2v #lancet #medicaljournal #medical #journal #research #pakistan #transgender #antimicrobialresistance #stigma #outofpocket #breastcancer #lungcancer #carcinomatosis #bangladesh #medicalofficers #deeplearning #clinicaltrials #headandneckcancer #cervicalcancer #cancerscreening #clinical #tuberculosis #publishing #publication

Our Lancet report on women, power, and cancer is finding resonance in Indian media https://lnkd.in/gphQfCKC #india #ncd #globalhealth #cancer #gender #womenhealth #breastcancer #coloncancer #genderequality #cervicalcancer

EPHMRA Webinar - 2023 Winners of the JH Award for best Conference Paper February 6 2024 - 14.00 – 14.45 UK time Speakers: Tracy Machado, Elma Research and Alberto Giovanni Leone, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Convenor: Marcel Slavenburg, SKIM and LDC member "Gender Identity Perspective - Deep Dive into Oncology Screening" Register here - https://lnkd.in/ghpkhtuN About the Paper In this award winning paper, Tracy Machado and Alberto Leone discussed a study on the access to healthcare experienced by transgender and gender diverse people, focusing on diagnostic and therapeutic pathways in oncology as well as clinical trial inclusion. This paper highlighted that there is a real need for specialists to be more responsive and empathetic to emerging patient populations. OncoGender is a self-funded project that aims to share light on a phenomenon that is still little known and understood: transgender and gender nonconforming (TGNC) people’s access to clinical check-ups, screening, and treatment. A privileged look at the issue of inclusivity of healthcare via the implementation of a compelling group of Italian specialists (market researchers and oncologists) and the collaboration with AIOM (Italian Association of Medical Oncology) resulted in powerful insights. Any questions just get in touch – generalmanager@ephmra.org

CALL FOR CO-EDITORS - special issue titled "Gender Equality, Toxicology, and One Health – Connections and Studies" in Frontiers in Toxicology Ida Due (member of www.plasticheal.eu) is co-leading an important initiative related to gender representation in toxicological studies. They are assembling a team of co-editors for a special issue titled "Gender Equality, Toxicology, and One Health – Connections and Studies" in Frontiers in Toxicology. Recognizing a significant research gap in this area, the goal is to shed light on the gender data gap and encourage more scientific publications addressing this issue. To bring this special issue to fruition, they are seeking individuals who are interested in either editing the issue or contributing articles to it. Your support in spreading the word across your own networks would be immensely valuable, so please feel free to share this invitation. Specifically, they are looking for assistance in the following areas: Calling for Co-Editors: Topic Editors with a minimum of a PhD degree and three or more years of post-doctoral and editorial experience. One Topic Editor must be a senior scientist (i.e., Associate Professor or above). Further details can be found in Frontiers in Toxicology's Research Topics Guidelines. Please help promote this special issue to researchers who may be interested in contributing their work. Should you have any questions or require additional information, please contact me at hello@cusp-research.eu Your support in making this endeavour a success is greatly appreciated.